Related Experiment Video
Updated: Jan 14, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Effectiveness of Nirsevimab in Preventing Respiratory Syncytial Virus-related Burden: A Test-negative Case-control
Eleonora Fusco1, Martina Loiodice2, Alice Romero2
1From the Paediatric Department, Buzzi Children's Hospital.
Abstract:
The effectiveness of nirsevimab in preventing the burden of respiratory syncytial virus (RSV)-bronchiolitis was evaluated with a test-negative case-control study in 208 infants presenting to Emergency Department. The effectiveness was 82% against RSV infection, 78% against RSV-related hospitalization, and 84% against intensive care admission. These real-world data support its inclusion in Italian immunization programs.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV

